Glutamate causes neuronal damage and eventual cell death, particularly when NMDA receptors are activated, High dosages of glutamic acid may include symptoms such as headaches and neurological problems.
A peptide that is a homopolymer of glutamic acid.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Amphetamine | The serum concentration of Amphetamine can be decreased when it is combined with Glutamic acid. |
| Phentermine | The serum concentration of Phentermine can be decreased when it is combined with Glutamic acid. |
| Pseudoephedrine | The serum concentration of Pseudoephedrine can be decreased when it is combined with Glutamic acid. |
| Benzphetamine | The serum concentration of Benzphetamine can be decreased when it is combined with Glutamic acid. |
| Diethylpropion | The serum concentration of Diethylpropion can be decreased when it is combined with Glutamic acid. |
| Lisdexamfetamine | The serum concentration of Lisdexamfetamine can be decreased when it is combined with Glutamic acid. |
| Mephentermine | The serum concentration of Mephentermine can be decreased when it is combined with Glutamic acid. |
| MMDA | The serum concentration of MMDA can be decreased when it is combined with Glutamic acid. |
| Midomafetamine | The serum concentration of Midomafetamine can be decreased when it is combined with Glutamic acid. |
| 2,5-Dimethoxy-4-ethylamphetamine | The serum concentration of 2,5-Dimethoxy-4-ethylamphetamine can be decreased when it is combined with Glutamic acid. |
| 4-Bromo-2,5-dimethoxyamphetamine | The serum concentration of 4-Bromo-2,5-dimethoxyamphetamine can be decreased when it is combined with Glutamic acid. |
| Tenamfetamine | The serum concentration of Tenamfetamine can be decreased when it is combined with Glutamic acid. |
| Chlorphentermine | The serum concentration of Chlorphentermine can be decreased when it is combined with Glutamic acid. |
| Methylenedioxyethamphetamine | The serum concentration of Methylenedioxyethamphetamine can be decreased when it is combined with Glutamic acid. |
| Dextroamphetamine | The serum concentration of Dextroamphetamine can be decreased when it is combined with Glutamic acid. |
| Metamfetamine | The serum concentration of Metamfetamine can be decreased when it is combined with Glutamic acid. |
| Iofetamine I-123 | The serum concentration of Iofetamine I-123 can be decreased when it is combined with Glutamic acid. |
| Ritobegron | The serum concentration of Ritobegron can be decreased when it is combined with Glutamic acid. |
| Mephedrone | The serum concentration of Mephedrone can be decreased when it is combined with Glutamic acid. |
| Methoxyphenamine | The serum concentration of Methoxyphenamine can be decreased when it is combined with Glutamic acid. |
| Gepefrine | The serum concentration of Gepefrine can be decreased when it is combined with Glutamic acid. |
| 2,5-Dimethoxy-4-ethylthioamphetamine | The serum concentration of 2,5-Dimethoxy-4-ethylthioamphetamine can be decreased when it is combined with Glutamic acid. |
| Phendimetrazine | The serum concentration of Phendimetrazine can be decreased when it is combined with Glutamic acid. |